These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22975727)

  • 1. The stereotypy-inducing effects of N-substituted benztropine analogs alone and in combination with cocaine do not account for their blockade of cocaine self-administration.
    Li L; Hiranita T; Hayashi S; Newman AH; Katz JL
    Psychopharmacology (Berl); 2013 Feb; 225(3):733-42. PubMed ID: 22975727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of reinforcing effects of benztropine analogs and their effects on cocaine self-administration in rats: comparisons with monoamine uptake inhibitors.
    Hiranita T; Soto PL; Newman AH; Katz JL
    J Pharmacol Exp Ther; 2009 May; 329(2):677-86. PubMed ID: 19228996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral economic analysis of the effects of N-substituted benztropine analogs on cocaine self-administration in rats.
    Zanettini C; Wilkinson DS; Katz JL
    Psychopharmacology (Berl); 2018 Jan; 235(1):47-58. PubMed ID: 28932889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of N-substituted analogs of benztropine: diminished cocaine-like effects in dopamine transporter ligands.
    Katz JL; Kopajtic TA; Agoston GE; Newman AH
    J Pharmacol Exp Ther; 2004 May; 309(2):650-60. PubMed ID: 14755006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. σ Receptor Effects of N-Substituted Benztropine Analogs: Implications for Antagonism of Cocaine Self-Administration.
    Hiranita T; Hong WC; Kopajtic T; Katz JL
    J Pharmacol Exp Ther; 2017 Jul; 362(1):2-13. PubMed ID: 28442581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Place conditioning and locomotor effects of N-substituted, 4',4''-difluorobenztropine analogs in rats.
    Li SM; Newman AH; Katz JL
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1223-30. PubMed ID: 15743929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine transporter binding without cocaine-like behavioral effects: synthesis and evaluation of benztropine analogs alone and in combination with cocaine in rodents.
    Katz JL; Agoston GE; Alling KL; Kline RH; Forster MJ; Woolverton WL; Kopajtic TA; Newman AH
    Psychopharmacology (Berl); 2001 Apr; 154(4):362-74. PubMed ID: 11349389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3'- and 4'-chloro-substituted analogs of benztropine: intravenous self-administration and in vitro radioligand binding studies in rhesus monkeys.
    Woolverton WL; Rowlett JK; Wilcox KM; Paul IA; Kline RH; Newman AH; Katz JL
    Psychopharmacology (Berl); 2000 Jan; 147(4):426-35. PubMed ID: 10672637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical efficacy of N-substituted benztropine analogs as antagonists of methamphetamine self-administration in rats.
    Hiranita T; Kohut SJ; Soto PL; Tanda G; Kopajtic TA; Katz JL
    J Pharmacol Exp Ther; 2014 Jan; 348(1):174-91. PubMed ID: 24194527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dopamine uptake inhibitor 3 alpha-[bis(4'-fluorophenyl)metoxy]-tropane reduces cocaine-induced early-gene expression, locomotor activity, and conditioned reward.
    Velázquez-Sánchez C; Ferragud A; Hernández-Rabaza V; Nácher A; Merino V; Cardá M; Murga J; Canales JJ
    Neuropsychopharmacology; 2009 Nov; 34(12):2497-507. PubMed ID: 19606084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dopamine transport inhibitor with markedly low abuse liability suppresses cocaine self-administration in the rat.
    Ferragud A; Velázquez-Sánchez C; Hernández-Rabaza V; Nácher A; Merino V; Cardá M; Murga J; Canales JJ
    Psychopharmacology (Berl); 2009 Dec; 207(2):281-9. PubMed ID: 19756525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further studies of the reinforcing effects of benztropine analogs in rhesus monkeys.
    Woolverton WL; Hecht GS; Agoston GE; Katz JL; Newman AH
    Psychopharmacology (Berl); 2001 Apr; 154(4):375-82. PubMed ID: 11349390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral and neurochemical effects of the dopamine transporter ligand 4-chlorobenztropine alone and in combination with cocaine in vivo.
    Tolliver BK; Newman AH; Katz JL; Ho LB; Fox LM; Hsu K; Berger SP
    J Pharmacol Exp Ther; 1999 Apr; 289(1):110-22. PubMed ID: 10086994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of methamphetamine's locomotor stimulation and self-administration by JHW 007, an atypical dopamine reuptake blocker.
    Ferragud A; Velázquez-Sánchez C; Canales JJ
    Eur J Pharmacol; 2014 May; 731():73-9. PubMed ID: 24675149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further delineation between typical and atypical dopamine uptake inhibitors: effects on food-maintained behavior and food consumption.
    Slezak JM; Desai RI; Katz JL
    Behav Pharmacol; 2017 Feb; 28(1):74-82. PubMed ID: 27926573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between in vivo occupancy at the dopamine transporter and behavioral effects of cocaine, GBR 12909 [1-{2-[bis-(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine], and benztropine analogs.
    Desai RI; Kopajtic TA; French D; Newman AH; Katz JL
    J Pharmacol Exp Ther; 2005 Oct; 315(1):397-404. PubMed ID: 16014753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics, brain distribution, and pharmacodynamics of 2nd generation dopamine transporter selective benztropine analogs developed as potential substitute therapeutics for treatment of cocaine abuse.
    Syed SA; Newman AH; Othman AA; Eddington ND
    J Pharm Sci; 2008 May; 97(5):1993-2007. PubMed ID: 17879975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applicability of the dopamine and rate hypotheses in explaining the differences in behavioral pharmacology of the chloro-benztropine analogs: studies conducted using intracerebral microdialysis and population pharmacodynamic modeling.
    Othman AA; Newman AH; Eddington ND
    J Pharmacol Exp Ther; 2007 Aug; 322(2):760-9. PubMed ID: 17519385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The high affinity dopamine uptake inhibitor, JHW 007, blocks cocaine-induced reward, locomotor stimulation and sensitization.
    Velázquez-Sánchez C; Ferragud A; Murga J; Cardá M; Canales JJ
    Eur Neuropsychopharmacol; 2010 Jul; 20(7):501-8. PubMed ID: 20413276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic-like properties of a dopamine uptake inhibitor in animal models of amphetamine addiction.
    Velazquez-Sanchez C; Ferragud A; Renau-Piqueras J; Canales JJ
    Int J Neuropsychopharmacol; 2011 Jun; 14(5):655-65. PubMed ID: 20735880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.